Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Issue Cover for Volume 22, Number 10—October 2016

Volume 22, Number 10—October 2016

[PDF - 38.32 MB - 173 pages]

Synopses

Outbreaks of Human Salmonella Infections Associated with Live Poultry, United States, 1990–2014 [PDF - 1.54 MB - 7 pages]
C. Basler et al.

Backyard poultry flocks have increased in popularity concurrent with an increase in live poultry–associated salmonellosis (LPAS) outbreaks. Better understanding of practices that contribute to this emerging public health issue is needed. We reviewed outbreak reports to describe the epidemiology of LPAS outbreaks in the United States, examine changes in trends, and inform prevention campaigns. LPAS outbreaks were defined as ≥2 culture-confirmed human Salmonella infections linked to live poultry contact. Outbreak data were obtained through multiple databases and a literature review. During 1990–2014, a total of 53 LPAS outbreaks were documented, involving 2,630 illnesses, 387 hospitalizations, and 5 deaths. Median patient age was 9 years (range <1 to 92 years). Chick and duckling exposure were reported by 85% and 38% of case-patients, respectively. High-risk practices included keeping poultry inside households (46% of case-patients) and kissing birds (13%). Comprehensive One Health strategies are needed to prevent illnesses associated with live poultry.

EID Basler C, Nguyen T, Anderson TC, Hancock T, Behravesh C. Outbreaks of Human Salmonella Infections Associated with Live Poultry, United States, 1990–2014. Emerg Infect Dis. 2016;22(10):1705-1711. https://dx.doi.org/10.3201/eid2210.150765
AMA Basler C, Nguyen T, Anderson TC, et al. Outbreaks of Human Salmonella Infections Associated with Live Poultry, United States, 1990–2014. Emerging Infectious Diseases. 2016;22(10):1705-1711. doi:10.3201/eid2210.150765.
APA Basler, C., Nguyen, T., Anderson, T. C., Hancock, T., & Behravesh, C. (2016). Outbreaks of Human Salmonella Infections Associated with Live Poultry, United States, 1990–2014. Emerging Infectious Diseases, 22(10), 1705-1711. https://dx.doi.org/10.3201/eid2210.150765.

Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014 [PDF - 580 KB - 8 pages]
M. Shaghaghi et al.

Widespread use of oral poliovirus vaccine has led to an ≈99.9% decrease in global incidence of poliomyelitis (from ≈350,000 cases in 1988 to 74 cases in 2015) and eradication of wild-type poliovirus serotypes 2 and 3. However, patients with primary immunodeficiency might shed vaccine-derived polioviruses (VDPVs) for an extended period, which could pose a major threat to polio eradication programs. Since 1995, sixteen VDPV populations have been isolated from 14 patients with immunodeficiency in Iran. For these patients, vaccine-associated paralysis, mostly in >1 extremity, was the first manifestation of primary immunodeficiency. Seven patients with humoral immunodeficiency cleared VDPV infection more frequently than did 6 patients with combined immunodeficiencies. Our results raise questions about manifestations of VDPVs in immunodeficient patients and the role of cellular immunity against enterovirus infections. On the basis of an association between VDPVs and immunodeficiency, we advocate screening of patients with primary immunodeficiency for shedding of polioviruses.

EID Shaghaghi M, Shahmahmoodi S, Abolhassani H, Soleyman-jahi S, Parvaneh L, Mahmoudi S, et al. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014. Emerg Infect Dis. 2016;22(10):1712-1719. https://dx.doi.org/10.3201/eid2210.151071
AMA Shaghaghi M, Shahmahmoodi S, Abolhassani H, et al. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014. Emerging Infectious Diseases. 2016;22(10):1712-1719. doi:10.3201/eid2210.151071.
APA Shaghaghi, M., Shahmahmoodi, S., Abolhassani, H., Soleyman-jahi, S., Parvaneh, L., Mahmoudi, S....Aghamohammadi, A. (2016). Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014. Emerging Infectious Diseases, 22(10), 1712-1719. https://dx.doi.org/10.3201/eid2210.151071.

Medscape CME Activity
Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis [PDF - 458 KB - 8 pages]
M. Abinun et al.

Severe infections are emerging as major risk factors for death among children with juvenile idiopathic arthritis (JIA). In particular, children with refractory JIA treated with long-term, multiple, and often combined immunosuppressive and antiinflammatory agents, including the new biological disease-modifying antirheumatic drugs (DMARDs), are at increased risk for severe infections and death. We investigated 4 persons with JIA who died during 1994–2013, three of overwhelming central venous catheter–related bacterial sepsis caused by coagulase-negative Staphylococus or α-hemolytic Streptococcus infection and 1 of disseminated adenovirus and Epstein-Barr virus infection). All 4 had active JIA refractory to long-term therapy with multiple and combined conventional and biological DMARDs. Two died while receiving high-dose systemic corticosteroids, methotrexate, and after recent exposure to anti–tumor necrosis factor-α biological DMARDs, and 2 during hematopoietic stem cell transplantation procedure. Reporting all cases of severe infections and especially deaths in these children is of paramount importance for accurate surveillance.

EID Abinun M, Lane JP, Wood M, Friswell M, Flood TJ, Foster HE. Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis. Emerg Infect Dis. 2016;22(10):1720-1727. https://dx.doi.org/10.3201/eid2210.151245
AMA Abinun M, Lane JP, Wood M, et al. Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis. Emerging Infectious Diseases. 2016;22(10):1720-1727. doi:10.3201/eid2210.151245.
APA Abinun, M., Lane, J. P., Wood, M., Friswell, M., Flood, T. J., & Foster, H. E. (2016). Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis. Emerging Infectious Diseases, 22(10), 1720-1727. https://dx.doi.org/10.3201/eid2210.151245.

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes [PDF - 964 KB - 9 pages]
D. Mesher et al.

We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods to consider possible changes in nonvaccine HPV genotypes after introduction of vaccines that confer protection against 2 high-risk types, HPV16 and HPV18. Our meta-analysis included 9 studies with data for 13,886 girls and women ≤19 years of age and 23,340 women 20–24 years of age. We found evidence of cross-protection for HPV31 among the younger age group after vaccine introduction but little evidence for reductions of HPV33 and HPV45. For the group this same age group, we also found slight increases in 2 nonvaccine high-risk HPV types (HPV39 and HPV52) and in 2 possible high-risk types (HPV53 and HPV73). However, results between age groups and vaccines used were inconsistent, and the increases had possible alternative explanations; consequently, these data provided no clear evidence for type replacement. Continued monitoring of these HPV genotypes is important.

EID Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton J, et al. Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerg Infect Dis. 2016;22(10):1732-1740. https://dx.doi.org/10.3201/eid2210.160675
AMA Mesher D, Soldan K, Lehtinen M, et al. Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerging Infectious Diseases. 2016;22(10):1732-1740. doi:10.3201/eid2210.160675.
APA Mesher, D., Soldan, K., Lehtinen, M., Beddows, S., Brisson, M., Brotherton, J....Thomas, S. L. (2016). Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerging Infectious Diseases, 22(10), 1732-1740. https://dx.doi.org/10.3201/eid2210.160675.

Accuracy of Diagnosis of Human Granulocytic Anaplasmosis in China [PDF - 355 KB - 4 pages]
G. P. Wormser

In 2008, human granulocytic anaplasmosis (HGA) was reported from China. However, the clinical and laboratory findings, including reports of nosocomial transmission, were inconsistent with those reported for HGA in the United States. In 2012, it was demonstrated that the patients described in the 2008 report had all been infected with a newly discovered bunyavirus, severe fever with thrombocytopenia syndrome virus, which causes an illness with the same clinical features described for the patients in the 2008 report. This finding raises the question of HGA misdiagnosis in China and establishes the need for further studies to determine whether HGA occurs there.

EID Wormser GP. Accuracy of Diagnosis of Human Granulocytic Anaplasmosis in China. Emerg Infect Dis. 2016;22(10):1728-1731. https://dx.doi.org/10.3201/eid2210.160161
AMA Wormser GP. Accuracy of Diagnosis of Human Granulocytic Anaplasmosis in China. Emerging Infectious Diseases. 2016;22(10):1728-1731. doi:10.3201/eid2210.160161.
APA Wormser, G. P. (2016). Accuracy of Diagnosis of Human Granulocytic Anaplasmosis in China. Emerging Infectious Diseases, 22(10), 1728-1731. https://dx.doi.org/10.3201/eid2210.160161.
Research

Cat-Scratch Disease in the United States, 2005–2013 [PDF - 687 KB - 6 pages]
C. A. Nelson et al.

Cat-scratch disease (CSD) is mostly preventable. More information about the epidemiology and extent of CSD would help direct prevention efforts to those at highest risk. To gain such information, we reviewed the 2005–2013 MarketScan national health insurance claims databases and identified patients <65 years of age with an inpatient admission or outpatient visit that included a CSD code from the International Classification of Diseases, Ninth Revision, Clinical Modification. Incidence of CSD was highest among those who lived in the southern United States (6.4 cases/100,000 population) and among children 5–9 years of age (9.4 cases/100,000 population). Inpatients were significantly more likely than outpatients to be male and 50–64 years of age. We estimate that each year, 12,000 outpatients are given a CSD diagnosis and 500 inpatients are hospitalized for CSD. Prevention measures (e.g., flea control for cats) are particularly helpful in southern states and in households with children.

EID Nelson CA, Saha S, Mead PS. Cat-Scratch Disease in the United States, 2005–2013. Emerg Infect Dis. 2016;22(10):1741-1746. https://dx.doi.org/10.3201/eid2210.160115
AMA Nelson CA, Saha S, Mead PS. Cat-Scratch Disease in the United States, 2005–2013. Emerging Infectious Diseases. 2016;22(10):1741-1746. doi:10.3201/eid2210.160115.
APA Nelson, C. A., Saha, S., & Mead, P. S. (2016). Cat-Scratch Disease in the United States, 2005–2013. Emerging Infectious Diseases, 22(10), 1741-1746. https://dx.doi.org/10.3201/eid2210.160115.

Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008−2013 [PDF - 2.28 MB - 7 pages]
S. M. Kotila et al.

We evaluated incidence, case-fatality rate, and trends of community-associated (CA) and healthcare-associated (HA) Clostridium difficile infections (CDIs) in Finland during 2008–2013. CDIs were identified in the National Infectious Disease Register, deaths in the National Population Information System, hospitalizations to classify infections as CA or HA in the National Hospital Discharge Register, and genotypes in a reference laboratory. A total of 32,991 CDIs were identified: 10,643 (32.3%) were CA (32.9 cases/100,000 population) and 22,348 (67.7%) HA (69.1/100,000). Overall annual incidence decreased from 118.7/100,000 in 2008 to 92.1/100,000 in 2013, which was caused by reduction in HA-CDI rates (average annual decrease 8.1%; p<0.001). The 30-day case-fatality rate was lower for CA-CDIs than for HA-CDIs (3.2% vs. 13.3%; p<0.001). PCR ribotypes 027 and 001 were more common in HA-CDIs than in CA-CDIs. Although the HA-CDI incidence rate decreased, which was probably caused by increased awareness and improved infection control, the CA-CDI rate increased.

EID Kotila SM, Mentula S, Ollgren J, Virolainen-Julkunen A, Lyytikäinen O. Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008−2013. Emerg Infect Dis. 2016;22(10):1747-1753. https://dx.doi.org/10.3201/eid2210.151492
AMA Kotila SM, Mentula S, Ollgren J, et al. Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008−2013. Emerging Infectious Diseases. 2016;22(10):1747-1753. doi:10.3201/eid2210.151492.
APA Kotila, S. M., Mentula, S., Ollgren, J., Virolainen-Julkunen, A., & Lyytikäinen, O. (2016). Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008−2013. Emerging Infectious Diseases, 22(10), 1747-1753. https://dx.doi.org/10.3201/eid2210.151492.

Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples [PDF - 1.12 MB - 8 pages]
G. Chowdhury et al.

Carbapenems have been used for many years to treat severe nosocomial Enterobacteriaceae infections. The spread of resistance to these drugs among other bacterial families is an emerging problem worldwide, mostly caused by New Delhi metallo-β-lactamase (NDM-1). We screened for the prevalence of NDM-1–expressing enteric pathogens from hospitalized patients with acute diarrhea in Kolkata, India, and identified 27 Vibrio fluvialis–harboring blaNDM-1 (NDM-VF) strains. These isolates were also resistant to all the tested antimicrobial drugs except doxycycline. The large plasmid of V. fluvialis harboring blaNDM-1 could be easily transferred to other enteric pathogens. Genes flanking the blaNDM-1 were found to be identical to the reported sequence from an Escherichia coli isolate. Analyses showed that the V. fluvialis possessing the NDM-VF region belonged to different clones. The pathogenicity of V. fluvialis to humans and its ubiquitous presence in the environment call for constant monitoring of this species for emerging antimicrobial drug resistance.

EID Chowdhury G, Pazhani G, Sarkar A, Rajendran K, Mukhopadhyay AK, Bhattacharya MK, et al. Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples. Emerg Infect Dis. 2016;22(10):1754-1761. https://dx.doi.org/10.3201/eid2210.151612
AMA Chowdhury G, Pazhani G, Sarkar A, et al. Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples. Emerging Infectious Diseases. 2016;22(10):1754-1761. doi:10.3201/eid2210.151612.
APA Chowdhury, G., Pazhani, G., Sarkar, A., Rajendran, K., Mukhopadhyay, A. K., Bhattacharya, M. K....Ramamurthy, T. (2016). Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples. Emerging Infectious Diseases, 22(10), 1754-1761. https://dx.doi.org/10.3201/eid2210.151612.

Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015 [PDF - 1.53 MB - 7 pages]
C. B. Kretz et al.

In 2015, Niger reported the largest epidemic of Neisseria meningitidis serogroup C (NmC) meningitis in sub-Saharan Africa. The NmC epidemic coincided with serogroup W (NmW) cases during the epidemic season, resulting in a total of 9,367 meningococcal cases through June 2015. To clarify the phylogenetic association, genetic evolution, and antibiotic determinants of the meningococcal strains in Niger, we sequenced the genomes of 102 isolates from this epidemic, comprising 81 NmC and 21 NmW isolates. The genomes of 82 isolates were completed, and all 102 were included in the analysis. All NmC isolates had sequence type 10217, which caused the outbreaks in Nigeria during 2013–2014 and for which a clonal complex has not yet been defined. The NmC isolates from Niger were substantially different from other NmC isolates collected globally. All NmW isolates belonged to clonal complex 11 and were closely related to the isolates causing recent outbreaks in Africa.

EID Kretz CB, Retchless AC, Sidikou F, Issaka B, Ousmane S, Schwartz S, et al. Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015. Emerg Infect Dis. 2016;22(10):1762-1768. https://dx.doi.org/10.3201/eid2210.160468
AMA Kretz CB, Retchless AC, Sidikou F, et al. Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015. Emerging Infectious Diseases. 2016;22(10):1762-1768. doi:10.3201/eid2210.160468.
APA Kretz, C. B., Retchless, A. C., Sidikou, F., Issaka, B., Ousmane, S., Schwartz, S....Wang, X. (2016). Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015. Emerging Infectious Diseases, 22(10), 1762-1768. https://dx.doi.org/10.3201/eid2210.160468.

Medscape CME Activity
Ebola Virus Disease in Children, Sierra Leone, 2014–2015 [PDF - 1.55 MB - 9 pages]
F. Fitzgerald et al.

Little is known about potentially modifiable factors in Ebola virus disease in children. We undertook a retrospective cohort study of children <13 years old admitted to 11 Ebola holding units in the Western Area, Sierra Leone, during 2014–2015 to identify factors affecting outcome. Primary outcome was death or discharge after transfer to Ebola treatment centers. All 309 Ebola virus–positive children 2 days–12 years old were included; outcomes were available for 282 (91%). Case-fatality was 57%, and 55% of deaths occurred in Ebola holding units. Blood test results showed hypoglycemia and hepatic/renal dysfunction. Death occurred swiftly (median 3 days after admission) and was associated with younger age and diarrhea. Despite triangulation of information from multiple sources, data availability was limited, and we identified no modifiable factors substantially affecting death. In future Ebola virus disease epidemics, robust, rapid data collection is vital to determine effectiveness of interventions for children.

EID Fitzgerald F, Naveed A, Wing K, Gbessay M, Ross J, Checchi F, et al. Ebola Virus Disease in Children, Sierra Leone, 2014–2015. Emerg Infect Dis. 2016;22(10):1769-1777. https://dx.doi.org/10.3201/eid2210.160579
AMA Fitzgerald F, Naveed A, Wing K, et al. Ebola Virus Disease in Children, Sierra Leone, 2014–2015. Emerging Infectious Diseases. 2016;22(10):1769-1777. doi:10.3201/eid2210.160579.
APA Fitzgerald, F., Naveed, A., Wing, K., Gbessay, M., Ross, J., Checchi, F....Yeung, S. (2016). Ebola Virus Disease in Children, Sierra Leone, 2014–2015. Emerging Infectious Diseases, 22(10), 1769-1777. https://dx.doi.org/10.3201/eid2210.160579.

Systematic Review and Meta-Analysis of Doxycycline Efficacy for Rectal Lymphogranuloma Venereum in Men Who Have Sex with Men [PDF - 611 KB - 7 pages]
C. Leeyaphan et al.

Rectal lymphogranuloma venereum (LGV) has reemerged as a sexually transmitted infection among men who have sex with men (MSM), particularly those who are HIV-positive. We undertook a systematic review and meta-analysis to determine the efficacy of doxycycline (100 mg 2×/d for 21 days) for rectal LGV in MSM. Nine studies were included: 4 prospective, 4 retrospective, and 1 combined retrospective and prospective. In total, 282 MSM with rectal LGV were included in the studies. All studies reported using nucleic acid amplification tests to assess microbial cure. Most patients (>80%) had symptomatic rectal infection. The fixed-effects pooled efficacy for doxycycline was 98.5% (95% CI 96.3%–100%, I2 = 0%; p = 0.993). Doxycycline at 100 mg twice daily for 21 days demonstrated a high microbial cure rate. These data support doxycycline at this dosage and duration as first-line therapy for rectal LGV in MSM.

EID Leeyaphan C, Ong JJ, Chow E, Kong F, Hocking JS, Bissessor M, et al. Systematic Review and Meta-Analysis of Doxycycline Efficacy for Rectal Lymphogranuloma Venereum in Men Who Have Sex with Men. Emerg Infect Dis. 2016;22(10):1778-1784. https://dx.doi.org/10.3201/eid2210.160986
AMA Leeyaphan C, Ong JJ, Chow E, et al. Systematic Review and Meta-Analysis of Doxycycline Efficacy for Rectal Lymphogranuloma Venereum in Men Who Have Sex with Men. Emerging Infectious Diseases. 2016;22(10):1778-1784. doi:10.3201/eid2210.160986.
APA Leeyaphan, C., Ong, J. J., Chow, E., Kong, F., Hocking, J. S., Bissessor, M....Chen, M. Y. (2016). Systematic Review and Meta-Analysis of Doxycycline Efficacy for Rectal Lymphogranuloma Venereum in Men Who Have Sex with Men. Emerging Infectious Diseases, 22(10), 1778-1784. https://dx.doi.org/10.3201/eid2210.160986.
Dispatches

Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015 [PDF - 718 KB - 3 pages]
K. S. Carville et al.

In Victoria, Australia, invasive meningococcal disease caused by Neisseria meningitidis serogroup W increased from 4% of all cases in 2013 to 30% in 2015. This increase resulted largely from strains similar to those in the serogroup W sequence type 11 clonal complex, previously described in the United Kingdom and South America.

EID Carville KS, Stevens K, Sohail A, Franklin LJ, Bond KA, Brahmi A, et al. Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015. Emerg Infect Dis. 2016;22(10):1785-1787. https://dx.doi.org/10.3201/eid2210.151935
AMA Carville KS, Stevens K, Sohail A, et al. Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015. Emerging Infectious Diseases. 2016;22(10):1785-1787. doi:10.3201/eid2210.151935.
APA Carville, K. S., Stevens, K., Sohail, A., Franklin, L. J., Bond, K. A., Brahmi, A....Ong, K. S. (2016). Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015. Emerging Infectious Diseases, 22(10), 1785-1787. https://dx.doi.org/10.3201/eid2210.151935.

Distinct Zika Virus Lineage in Salvador, Bahia, Brazil [PDF - 1.42 MB - 5 pages]
S. N. Naccache et al.

Sequencing of isolates from patients in Bahia, Brazil, where most Zika virus cases in Brazil have been reported, resulted in 11 whole and partial Zika virus genomes. Phylogenetic analyses revealed a well-supported Bahia-specific Zika virus lineage, which indicates sustained Zika virus circulation in Salvador, Bahia’s capital city, since mid-2014.

EID Naccache SN, Thézé J, Sardi SI, Somasekar S, Greninger AL, Bandeira AC, et al. Distinct Zika Virus Lineage in Salvador, Bahia, Brazil. Emerg Infect Dis. 2016;22(10):1788-1792. https://dx.doi.org/10.3201/eid2210.160663
AMA Naccache SN, Thézé J, Sardi SI, et al. Distinct Zika Virus Lineage in Salvador, Bahia, Brazil. Emerging Infectious Diseases. 2016;22(10):1788-1792. doi:10.3201/eid2210.160663.
APA Naccache, S. N., Thézé, J., Sardi, S. I., Somasekar, S., Greninger, A. L., Bandeira, A. C....Chiu, C. Y. (2016). Distinct Zika Virus Lineage in Salvador, Bahia, Brazil. Emerging Infectious Diseases, 22(10), 1788-1792. https://dx.doi.org/10.3201/eid2210.160663.

Streptococcus suis Serotype 2 Capsule In Vivo [PDF - 968 KB - 4 pages]
J. Auger et al.

Many Streptococcus suis isolates from porcine endocarditis in slaughterhouses have lost their capsule and are considered avirulent. However, we retrieved capsule- and virulence-recovered S. suis after in vivo passages of a nonencapsulated strain in mice, suggesting that nonencapsulated S. suis are still potentially hazardous for persons in the swine industry.

EID Auger J, Meekhanon N, Okura M, Osaki M, Gottschalk M, Sekizaki T, et al. Streptococcus suis Serotype 2 Capsule In Vivo. Emerg Infect Dis. 2016;22(10):1793-1796. https://dx.doi.org/10.3201/eid2210.151640
AMA Auger J, Meekhanon N, Okura M, et al. Streptococcus suis Serotype 2 Capsule In Vivo. Emerging Infectious Diseases. 2016;22(10):1793-1796. doi:10.3201/eid2210.151640.
APA Auger, J., Meekhanon, N., Okura, M., Osaki, M., Gottschalk, M., Sekizaki, T....Takamatsu, D. (2016). Streptococcus suis Serotype 2 Capsule In Vivo. Emerging Infectious Diseases, 22(10), 1793-1796. https://dx.doi.org/10.3201/eid2210.151640.

Estimation of Severe Middle East Respiratory Syndrome Cases in the Middle East, 2012–2016 [PDF - 410 KB - 3 pages]
J. J. O’Hagan et al.

Using data from travelers to 4 countries in the Middle East, we estimated 3,250 (95% CI 1,300–6,600) severe cases of Middle East respiratory syndrome occurred in this region during September 2012–January 2016. This number is 2.3-fold higher than the number of laboratory-confirmed cases recorded in these countries.

EID O’Hagan JJ, Carias C, Rudd JM, Pham HT, Haber Y, Pesik N, et al. Estimation of Severe Middle East Respiratory Syndrome Cases in the Middle East, 2012–2016. Emerg Infect Dis. 2016;22(10):1797-1799. https://dx.doi.org/10.3201/eid2210.151121
AMA O’Hagan JJ, Carias C, Rudd JM, et al. Estimation of Severe Middle East Respiratory Syndrome Cases in the Middle East, 2012–2016. Emerging Infectious Diseases. 2016;22(10):1797-1799. doi:10.3201/eid2210.151121.
APA O’Hagan, J. J., Carias, C., Rudd, J. M., Pham, H. T., Haber, Y., Pesik, N....Swerdlow, D. L. (2016). Estimation of Severe Middle East Respiratory Syndrome Cases in the Middle East, 2012–2016. Emerging Infectious Diseases, 22(10), 1797-1799. https://dx.doi.org/10.3201/eid2210.151121.

Chikungunya Virus in Febrile Humans and Aedes aegypti Mosquitoes, Yucatan, Mexico [PDF - 659 KB - 4 pages]
N. Cigarroa-Toledo et al.

Chikungunya virus (CHIKV) was isolated from 12 febrile humans in Yucatan, Mexico, in 2015. One patient was co-infected with dengue virus type 1. Two additional CHIKV isolates were obtained from Aedes aegypti mosquitoes collected in the homes of patients. Phylogenetic analysis showed that the CHIKV isolates belong to the Asian lineage.

EID Cigarroa-Toledo N, Blitvich BJ, Cetina-Trejo RC, Talavera-Aguilar LG, Baak-Baak CM, Torres-Chablé OM, et al. Chikungunya Virus in Febrile Humans and Aedes aegypti Mosquitoes, Yucatan, Mexico. Emerg Infect Dis. 2016;22(10):1804-1807. https://dx.doi.org/10.3201/eid2210.152087
AMA Cigarroa-Toledo N, Blitvich BJ, Cetina-Trejo RC, et al. Chikungunya Virus in Febrile Humans and Aedes aegypti Mosquitoes, Yucatan, Mexico. Emerging Infectious Diseases. 2016;22(10):1804-1807. doi:10.3201/eid2210.152087.
APA Cigarroa-Toledo, N., Blitvich, B. J., Cetina-Trejo, R. C., Talavera-Aguilar, L. G., Baak-Baak, C. M., Torres-Chablé, O. M....Machain-Williams, C. (2016). Chikungunya Virus in Febrile Humans and Aedes aegypti Mosquitoes, Yucatan, Mexico. Emerging Infectious Diseases, 22(10), 1804-1807. https://dx.doi.org/10.3201/eid2210.152087.

Daily Reportable Disease Spatiotemporal Cluster Detection, New York City, New York, USA, 2014–2015 [PDF - 937 KB - 5 pages]
S. K. Greene et al.

Each day, the New York City Department of Health and Mental Hygiene uses the free SaTScan software to apply prospective space–time permutation scan statistics to strengthen early outbreak detection for 35 reportable diseases. This method prompted early detection of outbreaks of community-acquired legionellosis and shigellosis.

EID Greene SK, Peterson ER, Kapell D, Fine AD, Kulldorff M. Daily Reportable Disease Spatiotemporal Cluster Detection, New York City, New York, USA, 2014–2015. Emerg Infect Dis. 2016;22(10):1808-1812. https://dx.doi.org/10.3201/eid2210.160097
AMA Greene SK, Peterson ER, Kapell D, et al. Daily Reportable Disease Spatiotemporal Cluster Detection, New York City, New York, USA, 2014–2015. Emerging Infectious Diseases. 2016;22(10):1808-1812. doi:10.3201/eid2210.160097.
APA Greene, S. K., Peterson, E. R., Kapell, D., Fine, A. D., & Kulldorff, M. (2016). Daily Reportable Disease Spatiotemporal Cluster Detection, New York City, New York, USA, 2014–2015. Emerging Infectious Diseases, 22(10), 1808-1812. https://dx.doi.org/10.3201/eid2210.160097.

Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection [PDF - 1.28 MB - 4 pages]
S. Kim et al.

We evaluated the diagnostic and clinical usefulness of blood specimens to detect Middle East respiratory syndrome coronavirus infection in 21 patients from the 2015 outbreak in South Korea. Viral RNA was detected in blood from 33% of patients at initial diagnosis, and the detection preceded a worse clinical course.

EID Kim S, Park S, Cho S, Cha R, Jee H, Kim G, et al. Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection. Emerg Infect Dis. 2016;22(10):1813-1816. https://dx.doi.org/10.3201/eid2210.160218
AMA Kim S, Park S, Cho S, et al. Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection. Emerging Infectious Diseases. 2016;22(10):1813-1816. doi:10.3201/eid2210.160218.
APA Kim, S., Park, S., Cho, S., Cha, R., Jee, H., Kim, G....Seong, M. (2016). Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection. Emerging Infectious Diseases, 22(10), 1813-1816. https://dx.doi.org/10.3201/eid2210.160218.

Sporotrichosis-Associated Hospitalizations, United States, 2000–2013 [PDF - 795 KB - 4 pages]
J. Gold et al.

To determine frequency and risk for sporotrichosis-associated hospitalizations, we analyzed the US 2000–2013 National (Nationwide) Inpatient Sample. An estimated 1,471 hospitalizations occurred (average annual rate 0.35/1 million persons). Hospitalizations were associated with HIV/AIDS, immune-mediated inflammatory diseases, and chronic obstructive pulmonary disease. Although rare, severe sporotrichosis should be considered for at-risk patients.

EID Gold J, Derado G, Mody RK, Benedict K. Sporotrichosis-Associated Hospitalizations, United States, 2000–2013. Emerg Infect Dis. 2016;22(10):1817-1820. https://dx.doi.org/10.3201/eid2210.160671
AMA Gold J, Derado G, Mody RK, et al. Sporotrichosis-Associated Hospitalizations, United States, 2000–2013. Emerging Infectious Diseases. 2016;22(10):1817-1820. doi:10.3201/eid2210.160671.
APA Gold, J., Derado, G., Mody, R. K., & Benedict, K. (2016). Sporotrichosis-Associated Hospitalizations, United States, 2000–2013. Emerging Infectious Diseases, 22(10), 1817-1820. https://dx.doi.org/10.3201/eid2210.160671.

Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths, United States [PDF - 374 KB - 3 pages]
J. A. Noble et al.

Because coccidioidomycosis death rates vary by region, we reanalyzed coccidioidomycosis-associated mortality in the United States by race/ethnicity, then limited analysis to Arizona and California. Coccidioidomycosis-associated deaths were shown to increase among African-Americans but decrease among Native Americans and Hispanics. Separately, in a Native American cohort, diabetes co-varied with coccidioidomycosis-associated death.

EID Noble JA, Nelson RG, Fufaa GD, Kang P, Shafir S, Galgiani JN. Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths, United States. Emerg Infect Dis. 2016;22(10):1821-1823. https://dx.doi.org/10.3201/eid2210.160696
AMA Noble JA, Nelson RG, Fufaa GD, et al. Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths, United States. Emerging Infectious Diseases. 2016;22(10):1821-1823. doi:10.3201/eid2210.160696.
APA Noble, J. A., Nelson, R. G., Fufaa, G. D., Kang, P., Shafir, S., & Galgiani, J. N. (2016). Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths, United States. Emerging Infectious Diseases, 22(10), 1821-1823. https://dx.doi.org/10.3201/eid2210.160696.

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus [PDF - 426 KB - 3 pages]
D. C. Payne et al.

To determine how long antibodies against Middle East respiratory syndrome coronavirus persist, we measured long-term antibody responses among persons serologically positive or indeterminate after a 2012 outbreak in Jordan. Antibodies, including neutralizing antibodies, were detectable in 6 (86%) of 7 persons for at least 34 months after the outbreak.

EID Payne DC, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M, et al. Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016;22(10):1824-1826. https://dx.doi.org/10.3201/eid2210.160706
AMA Payne DC, Iblan I, Rha B, et al. Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. Emerging Infectious Diseases. 2016;22(10):1824-1826. doi:10.3201/eid2210.160706.
APA Payne, D. C., Iblan, I., Rha, B., Alqasrawi, S., Haddadin, A., Al Nsour, M....Al Abdallat, M. (2016). Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. Emerging Infectious Diseases, 22(10), 1824-1826. https://dx.doi.org/10.3201/eid2210.160706.

Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015 [PDF - 1.39 MB - 3 pages]
M. E. Coldiron et al.

We describe clinical symptoms, case-fatality rates, and prevalence of sequelae during an outbreak of Neisseria meningitidis serogroup C infection in a rural district of Niger. During home visits, we established that household contacts of reported case-patients were at higher risk for developing meningitis than the general population.

EID Coldiron ME, Salou H, Sidikou F, Goumbi K, Djibo A, Lechevalier P, et al. Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015. Emerg Infect Dis. 2016;22(10):1827-1829. https://dx.doi.org/10.3201/eid2210.160731
AMA Coldiron ME, Salou H, Sidikou F, et al. Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015. Emerging Infectious Diseases. 2016;22(10):1827-1829. doi:10.3201/eid2210.160731.
APA Coldiron, M. E., Salou, H., Sidikou, F., Goumbi, K., Djibo, A., Lechevalier, P....Grais, R. F. (2016). Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015. Emerging Infectious Diseases, 22(10), 1827-1829. https://dx.doi.org/10.3201/eid2210.160731.

Reemergence of Mycobacterium chimaera in Heater–Cooler Units despite Intensified Cleaning and Disinfection Protocol [PDF - 1.03 MB - 4 pages]
P. W. Schreiber et al.

Invasive Mycobacterium chimaera infections after open-heart surgery have been reported internationally. These devastating infections result from aerosols generated by contaminated heater–cooler units used with extracorporeal circulation during surgery. Despite intensified cleaning and disinfection, surveillance samples from factory-new units acquired during 2014 grew nontuberculous mycobacteria after a median of 174 days.

EID Schreiber PW, Kuster SP, Hasse B, Bayard C, Rüegg C, Kohler P, et al. Reemergence of Mycobacterium chimaera in Heater–Cooler Units despite Intensified Cleaning and Disinfection Protocol. Emerg Infect Dis. 2016;22(10):1830-1833. https://dx.doi.org/10.3201/eid2210.160925
AMA Schreiber PW, Kuster SP, Hasse B, et al. Reemergence of Mycobacterium chimaera in Heater–Cooler Units despite Intensified Cleaning and Disinfection Protocol. Emerging Infectious Diseases. 2016;22(10):1830-1833. doi:10.3201/eid2210.160925.
APA Schreiber, P. W., Kuster, S. P., Hasse, B., Bayard, C., Rüegg, C., Kohler, P....Sax, H. (2016). Reemergence of Mycobacterium chimaera in Heater–Cooler Units despite Intensified Cleaning and Disinfection Protocol. Emerging Infectious Diseases, 22(10), 1830-1833. https://dx.doi.org/10.3201/eid2210.160925.

Hypervirulent Clone of Group B Streptococcus Serotype III Sequence Type 283, Hong Kong, 1993–2012 [PDF - 818 KB - 4 pages]
M. Ip et al.

We describe a hypervirulent clone of group B Streptococcus serotype III, subtype 4, sequence type 283, that caused invasive disease with a predilection for meningitis in Hong Kong during 1993–2012. The organism is associated with high mortality and increased summer prevalence and is linked to diseased fish from freshwater fish farms.

EID Ip M, Ang I, Fung K, Liyanapathirana V, Luo M, Lai R. Hypervirulent Clone of Group B Streptococcus Serotype III Sequence Type 283, Hong Kong, 1993–2012. Emerg Infect Dis. 2016;22(10):1800-1803. https://dx.doi.org/10.3201/eid2210.151436
AMA Ip M, Ang I, Fung K, et al. Hypervirulent Clone of Group B Streptococcus Serotype III Sequence Type 283, Hong Kong, 1993–2012. Emerging Infectious Diseases. 2016;22(10):1800-1803. doi:10.3201/eid2210.151436.
APA Ip, M., Ang, I., Fung, K., Liyanapathirana, V., Luo, M., & Lai, R. (2016). Hypervirulent Clone of Group B Streptococcus Serotype III Sequence Type 283, Hong Kong, 1993–2012. Emerging Infectious Diseases, 22(10), 1800-1803. https://dx.doi.org/10.3201/eid2210.151436.
Letters

Synovial Tissue Infection with Burkholderia fungorum [PDF - 307 KB - 2 pages]
S. Loong et al.
EID Loong S, Soh Y, Mahfodz N, Johari J, AbuBakar S. Synovial Tissue Infection with Burkholderia fungorum. Emerg Infect Dis. 2016;22(10):1834-1835. https://dx.doi.org/10.3201/eid2210.151114
AMA Loong S, Soh Y, Mahfodz N, et al. Synovial Tissue Infection with Burkholderia fungorum. Emerging Infectious Diseases. 2016;22(10):1834-1835. doi:10.3201/eid2210.151114.
APA Loong, S., Soh, Y., Mahfodz, N., Johari, J., & AbuBakar, S. (2016). Synovial Tissue Infection with Burkholderia fungorum. Emerging Infectious Diseases, 22(10), 1834-1835. https://dx.doi.org/10.3201/eid2210.151114.

Naegleria fowleri Meningoencephalitis Associated with Public Water Supply, Pakistan, 2014 [PDF - 368 KB - 3 pages]
N. K. Ghanchi et al.
EID Ghanchi NK, Khan E, Khan A, Muhammad W, Malik F, Zafar A. Naegleria fowleri Meningoencephalitis Associated with Public Water Supply, Pakistan, 2014. Emerg Infect Dis. 2016;22(10):1835-1837. https://dx.doi.org/10.3201/eid2210.151236
AMA Ghanchi NK, Khan E, Khan A, et al. Naegleria fowleri Meningoencephalitis Associated with Public Water Supply, Pakistan, 2014. Emerging Infectious Diseases. 2016;22(10):1835-1837. doi:10.3201/eid2210.151236.
APA Ghanchi, N. K., Khan, E., Khan, A., Muhammad, W., Malik, F., & Zafar, A. (2016). Naegleria fowleri Meningoencephalitis Associated with Public Water Supply, Pakistan, 2014. Emerging Infectious Diseases, 22(10), 1835-1837. https://dx.doi.org/10.3201/eid2210.151236.

Unmet Needs for a Rapid Diagnosis of Chikungunya Virus Infection [PDF - 329 KB - 3 pages]
E. Burdino et al.
EID Burdino E, Calleri G, Caramello P, Ghisetti V. Unmet Needs for a Rapid Diagnosis of Chikungunya Virus Infection. Emerg Infect Dis. 2016;22(10):1837-1839. https://dx.doi.org/10.3201/eid2210.151784
AMA Burdino E, Calleri G, Caramello P, et al. Unmet Needs for a Rapid Diagnosis of Chikungunya Virus Infection. Emerging Infectious Diseases. 2016;22(10):1837-1839. doi:10.3201/eid2210.151784.
APA Burdino, E., Calleri, G., Caramello, P., & Ghisetti, V. (2016). Unmet Needs for a Rapid Diagnosis of Chikungunya Virus Infection. Emerging Infectious Diseases, 22(10), 1837-1839. https://dx.doi.org/10.3201/eid2210.151784.

Novel Single-Stranded DNA Circular Viruses in Pericardial Fluid of Patient with Recurrent Pericarditis [PDF - 444 KB - 3 pages]
S. Halary et al.
EID Halary S, Duraisamy R, Fancello L, Monteil-Bouchard S, Jardot P, Biagini P, et al. Novel Single-Stranded DNA Circular Viruses in Pericardial Fluid of Patient with Recurrent Pericarditis. Emerg Infect Dis. 2016;22(10):1839-1841. https://dx.doi.org/10.3201/eid2210.160052
AMA Halary S, Duraisamy R, Fancello L, et al. Novel Single-Stranded DNA Circular Viruses in Pericardial Fluid of Patient with Recurrent Pericarditis. Emerging Infectious Diseases. 2016;22(10):1839-1841. doi:10.3201/eid2210.160052.
APA Halary, S., Duraisamy, R., Fancello, L., Monteil-Bouchard, S., Jardot, P., Biagini, P....Desnues, C. (2016). Novel Single-Stranded DNA Circular Viruses in Pericardial Fluid of Patient with Recurrent Pericarditis. Emerging Infectious Diseases, 22(10), 1839-1841. https://dx.doi.org/10.3201/eid2210.160052.

Reemergence of Japanese Encephalitis in South Korea, 2010–2015 [PDF - 343 KB - 3 pages]
J. Sunwoo et al.
EID Sunwoo J, Jung K, Lee S, Lee S, Chu K. Reemergence of Japanese Encephalitis in South Korea, 2010–2015. Emerg Infect Dis. 2016;22(10):1841-1843. https://dx.doi.org/10.3201/eid2210.160288
AMA Sunwoo J, Jung K, Lee S, et al. Reemergence of Japanese Encephalitis in South Korea, 2010–2015. Emerging Infectious Diseases. 2016;22(10):1841-1843. doi:10.3201/eid2210.160288.
APA Sunwoo, J., Jung, K., Lee, S., Lee, S., & Chu, K. (2016). Reemergence of Japanese Encephalitis in South Korea, 2010–2015. Emerging Infectious Diseases, 22(10), 1841-1843. https://dx.doi.org/10.3201/eid2210.160288.

Recombinant Enterovirus A71 Subgenogroup C1 Strains, Germany, 2015 [PDF - 527 KB - 4 pages]
S. Böttcher et al.
EID Böttcher S, Obermeier PE, Neubauer K, Diedrich S. Recombinant Enterovirus A71 Subgenogroup C1 Strains, Germany, 2015. Emerg Infect Dis. 2016;22(10):1843-1846. https://dx.doi.org/10.3201/eid2210.160357
AMA Böttcher S, Obermeier PE, Neubauer K, et al. Recombinant Enterovirus A71 Subgenogroup C1 Strains, Germany, 2015. Emerging Infectious Diseases. 2016;22(10):1843-1846. doi:10.3201/eid2210.160357.
APA Böttcher, S., Obermeier, P. E., Neubauer, K., & Diedrich, S. (2016). Recombinant Enterovirus A71 Subgenogroup C1 Strains, Germany, 2015. Emerging Infectious Diseases, 22(10), 1843-1846. https://dx.doi.org/10.3201/eid2210.160357.

Cerebral Syphilitic Gumma within 5 Months of Syphilis in HIV-Infected Patient [PDF - 539 KB - 3 pages]
M. Tsuboi et al.
EID Tsuboi M, Nishijima T, Teruya K, Kikuchi Y, Gatanaga H, Oka S. Cerebral Syphilitic Gumma within 5 Months of Syphilis in HIV-Infected Patient. Emerg Infect Dis. 2016;22(10):1846-1848. https://dx.doi.org/10.3201/eid2210.160600
AMA Tsuboi M, Nishijima T, Teruya K, et al. Cerebral Syphilitic Gumma within 5 Months of Syphilis in HIV-Infected Patient. Emerging Infectious Diseases. 2016;22(10):1846-1848. doi:10.3201/eid2210.160600.
APA Tsuboi, M., Nishijima, T., Teruya, K., Kikuchi, Y., Gatanaga, H., & Oka, S. (2016). Cerebral Syphilitic Gumma within 5 Months of Syphilis in HIV-Infected Patient. Emerging Infectious Diseases, 22(10), 1846-1848. https://dx.doi.org/10.3201/eid2210.160600.

African Tick-Bite Fever in Traveler Returning to Slovenia from Uganda [PDF - 306 KB - 9 pages]
P. Bogovic et al.
EID Bogovic P, Lotric-Furlan S, Korva M, Avsic-Zupanc T. African Tick-Bite Fever in Traveler Returning to Slovenia from Uganda. Emerg Infect Dis. 2016;22(10):1848-1849. https://dx.doi.org/10.3201/eid2210.160650
AMA Bogovic P, Lotric-Furlan S, Korva M, et al. African Tick-Bite Fever in Traveler Returning to Slovenia from Uganda. Emerging Infectious Diseases. 2016;22(10):1848-1849. doi:10.3201/eid2210.160650.
APA Bogovic, P., Lotric-Furlan, S., Korva, M., & Avsic-Zupanc, T. (2016). African Tick-Bite Fever in Traveler Returning to Slovenia from Uganda. Emerging Infectious Diseases, 22(10), 1848-1849. https://dx.doi.org/10.3201/eid2210.160650.

Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil [PDF - 455 KB - 3 pages]
F. Bartolleti et al.
EID Bartolleti F, Seco B, Capuzzo dos Santos C, Felipe C, Lemo M, Alves T, et al. Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil. Emerg Infect Dis. 2016;22(10):1849-1851. https://dx.doi.org/10.3201/eid2210.160695
AMA Bartolleti F, Seco B, Capuzzo dos Santos C, et al. Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil. Emerging Infectious Diseases. 2016;22(10):1849-1851. doi:10.3201/eid2210.160695.
APA Bartolleti, F., Seco, B., Capuzzo dos Santos, C., Felipe, C., Lemo, M., Alves, T....Sampaio, J. (2016). Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil. Emerging Infectious Diseases, 22(10), 1849-1851. https://dx.doi.org/10.3201/eid2210.160695.

Resolution of a Chikungunya Outbreak in a Prospective Cohort, Cebu, Philippines, 2012–2014 [PDF - 312 KB - 3 pages]
A. Srikiatkhachorn et al.
EID Srikiatkhachorn A, Alera M, Lago CB, Tac-An IA, Villa D, Fernandez S, et al. Resolution of a Chikungunya Outbreak in a Prospective Cohort, Cebu, Philippines, 2012–2014. Emerg Infect Dis. 2016;22(10):1852-1854. https://dx.doi.org/10.3201/eid2210.160729
AMA Srikiatkhachorn A, Alera M, Lago CB, et al. Resolution of a Chikungunya Outbreak in a Prospective Cohort, Cebu, Philippines, 2012–2014. Emerging Infectious Diseases. 2016;22(10):1852-1854. doi:10.3201/eid2210.160729.
APA Srikiatkhachorn, A., Alera, M., Lago, C. B., Tac-An, I. A., Villa, D., Fernandez, S....Yoon, I. (2016). Resolution of a Chikungunya Outbreak in a Prospective Cohort, Cebu, Philippines, 2012–2014. Emerging Infectious Diseases, 22(10), 1852-1854. https://dx.doi.org/10.3201/eid2210.160729.

Resurgence of Yellow Fever in Angola, 2015–2016 [PDF - 372 KB - 2 pages]
A. A. Grobbelaar et al.
EID Grobbelaar AA, Weyer J, Moolla N, Jansen van Vuren P, Moises F, Pawęska JT. Resurgence of Yellow Fever in Angola, 2015–2016. Emerg Infect Dis. 2016;22(10):1854-1855. https://dx.doi.org/10.3201/eid2210.160818
AMA Grobbelaar AA, Weyer J, Moolla N, et al. Resurgence of Yellow Fever in Angola, 2015–2016. Emerging Infectious Diseases. 2016;22(10):1854-1855. doi:10.3201/eid2210.160818.
APA Grobbelaar, A. A., Weyer, J., Moolla, N., Jansen van Vuren, P., Moises, F., & Pawęska, J. T. (2016). Resurgence of Yellow Fever in Angola, 2015–2016. Emerging Infectious Diseases, 22(10), 1854-1855. https://dx.doi.org/10.3201/eid2210.160818.

Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016 [PDF - 406 KB - 3 pages]
J. Harrower et al.
EID Harrower J, Kiedrzynski T, Baker S, Upton A, Rahnama F, Sherwood J, et al. Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016. Emerg Infect Dis. 2016;22(10):1855-1857. https://dx.doi.org/10.3201/eid2210.160951
AMA Harrower J, Kiedrzynski T, Baker S, et al. Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016. Emerging Infectious Diseases. 2016;22(10):1855-1857. doi:10.3201/eid2210.160951.
APA Harrower, J., Kiedrzynski, T., Baker, S., Upton, A., Rahnama, F., Sherwood, J....Pulford, D. (2016). Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016. Emerging Infectious Diseases, 22(10), 1855-1857. https://dx.doi.org/10.3201/eid2210.160951.

Culex pipiens and Aedes triseriatus Mosquito Susceptibility to Zika Virus [PDF - 337 KB - 3 pages]
M. T. Aliota et al.
EID Aliota MT, Peinado SA, Osorio JE, Bartholomay LC. Culex pipiens and Aedes triseriatus Mosquito Susceptibility to Zika Virus. Emerg Infect Dis. 2016;22(10):1857-1859. https://dx.doi.org/10.3201/eid2210.161082
AMA Aliota MT, Peinado SA, Osorio JE, et al. Culex pipiens and Aedes triseriatus Mosquito Susceptibility to Zika Virus. Emerging Infectious Diseases. 2016;22(10):1857-1859. doi:10.3201/eid2210.161082.
APA Aliota, M. T., Peinado, S. A., Osorio, J. E., & Bartholomay, L. C. (2016). Culex pipiens and Aedes triseriatus Mosquito Susceptibility to Zika Virus. Emerging Infectious Diseases, 22(10), 1857-1859. https://dx.doi.org/10.3201/eid2210.161082.

Yellow Fever—More a Policy and Planning Problem than a Biological One [PDF - 273 KB - 2 pages]
C. H. Calisher and J. P. Woodall
EID Calisher CH, Woodall JP. Yellow Fever—More a Policy and Planning Problem than a Biological One. Emerg Infect Dis. 2016;22(10):1859-1860. https://dx.doi.org/10.3201/eid2210.160875
AMA Calisher CH, Woodall JP. Yellow Fever—More a Policy and Planning Problem than a Biological One. Emerging Infectious Diseases. 2016;22(10):1859-1860. doi:10.3201/eid2210.160875.
APA Calisher, C. H., & Woodall, J. P. (2016). Yellow Fever—More a Policy and Planning Problem than a Biological One. Emerging Infectious Diseases, 22(10), 1859-1860. https://dx.doi.org/10.3201/eid2210.160875.
Books and Media

Pandemic [PDF - 243 KB - 1 page]
J. B. Nuzzo
EID Nuzzo JB. Pandemic. Emerg Infect Dis. 2016;22(10):1862. https://dx.doi.org/10.3201/eid2210.160795
AMA Nuzzo JB. Pandemic. Emerging Infectious Diseases. 2016;22(10):1862. doi:10.3201/eid2210.160795.
APA Nuzzo, J. B. (2016). Pandemic. Emerging Infectious Diseases, 22(10), 1862. https://dx.doi.org/10.3201/eid2210.160795.
About the Cover

Geometric Abstract Art and Public Health Data [PDF - 539 KB - 2 pages]
S. Semaan
EID Semaan S. Geometric Abstract Art and Public Health Data. Emerg Infect Dis. 2016;22(10):1863-1864. https://dx.doi.org/10.3201/eid2210.ac2210
AMA Semaan S. Geometric Abstract Art and Public Health Data. Emerging Infectious Diseases. 2016;22(10):1863-1864. doi:10.3201/eid2210.ac2210.
APA Semaan, S. (2016). Geometric Abstract Art and Public Health Data. Emerging Infectious Diseases, 22(10), 1863-1864. https://dx.doi.org/10.3201/eid2210.ac2210.
Etymologia

Etymologia: Aedes aegypti [PDF - 356 KB - 1 page]
EID Etymologia: Aedes aegypti. Emerg Infect Dis. 2016;22(10):1807. https://dx.doi.org/10.3201/eid2210.et2210
AMA Etymologia: Aedes aegypti. Emerging Infectious Diseases. 2016;22(10):1807. doi:10.3201/eid2210.et2210.
APA (2016). Etymologia: Aedes aegypti. Emerging Infectious Diseases, 22(10), 1807. https://dx.doi.org/10.3201/eid2210.et2210.
Online Reports

Global Capacity for Emerging Infectious Disease Detection, 1996–2014 [PDF - 2.73 MB - 9 pages]
S. A. Kluberg et al.

The speed with which disease outbreaks are recognized is critical for establishing effective control efforts. We evaluate global improvements in the timeliness of outbreak discovery and communication during 2010–2014 as a follow-up to a 2010 report. For all outbreaks reported by the World Health Organization’s Disease Outbreak News, we estimate the number of days from first symptoms until outbreak discovery and until first public communication. We report median discovery and communication delays overall, by region, and by Human Development Index (HDI) quartile. We use Cox proportional hazards regression to assess changes in these 2 outcomes over time, along with Loess curves for visualization. Improvement since 1996 was greatest in the Eastern Mediterranean and Western Pacific regions and in countries in the middle HDI quartiles. However, little progress has occurred since 2010. Further improvements in surveillance will likely require additional international collaboration with a focus on regions of low or unstable HDI.

Corrections

Correction: Vol. 22, No. 4 [PDF - 707 KB - 1 page]
EID Correction: Vol. 22, No. 4. Emerg Infect Dis. 2016;22(10):1861. https://dx.doi.org/10.3201/eid2210.c12210
AMA Correction: Vol. 22, No. 4. Emerging Infectious Diseases. 2016;22(10):1861. doi:10.3201/eid2210.c12210.
APA (2016). Correction: Vol. 22, No. 4. Emerging Infectious Diseases, 22(10), 1861. https://dx.doi.org/10.3201/eid2210.c12210.

Correction: Vol. 22, No. 6 [PDF - 707 KB - 2 pages]
EID Correction: Vol. 22, No. 6. Emerg Infect Dis. 2016;22(10):1861. https://dx.doi.org/10.3201/eid2210.c22210
AMA Correction: Vol. 22, No. 6. Emerging Infectious Diseases. 2016;22(10):1861. doi:10.3201/eid2210.c22210.
APA (2016). Correction: Vol. 22, No. 6. Emerging Infectious Diseases, 22(10), 1861. https://dx.doi.org/10.3201/eid2210.c22210.

Correction: Vol. 22, No. 6 [PDF - 707 KB - 1 page]
EID Correction: Vol. 22, No. 6. Emerg Infect Dis. 2016;22(10):1861. https://dx.doi.org/10.3201/eid2210.c32210
AMA Correction: Vol. 22, No. 6. Emerging Infectious Diseases. 2016;22(10):1861. doi:10.3201/eid2210.c32210.
APA (2016). Correction: Vol. 22, No. 6. Emerging Infectious Diseases, 22(10), 1861. https://dx.doi.org/10.3201/eid2210.c32210.

Correction: Vol. 22, No. 6 [PDF - 707 KB - 1 page]
EID Correction: Vol. 22, No. 6. Emerg Infect Dis. 2016;22(10):1861. https://dx.doi.org/10.3201/eid2210.c42210
AMA Correction: Vol. 22, No. 6. Emerging Infectious Diseases. 2016;22(10):1861. doi:10.3201/eid2210.c42210.
APA (2016). Correction: Vol. 22, No. 6. Emerging Infectious Diseases, 22(10), 1861. https://dx.doi.org/10.3201/eid2210.c42210.
Page created: February 08, 2018
Page updated: February 08, 2018
Page reviewed: February 08, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 Submit ManuscriptExternal Link
Issue Select
GO
GO

Get Email Updates

To receive email updates about this page, enter your email address:

file_external